Forget the arm cuff—a smart wristband can now track your blood pressure. Hilo Core, a wearable that uses optical sensors to measure blood pressure and syncs with a smartphone app, has officially launched in the United States. The device aims to simplify daily health monitoring for millions of Americans, potentially changing how hypertension is managed outside the doctor's office.
Hilo Core is a wrist-mounted band that replaces the traditional inflatable cuff with photoplethysmography (PPG) sensors—the same technology used in smartwatches to measure heart rate. The band continuously collects blood pressure data and transmits it to a dedicated app for trend analysis and clinical reports. Its U.S. debut comes as the wearable health market grows rapidly, with consumers seeking non-invasive, continuous monitoring tools.
The product enters a competitive landscape. Companies like Omron and Withings already offer cuff-based smart monitors, while Apple and Samsung have experimented with optical blood pressure sensing but have not yet brought a dedicated device to market. Hilo Core's advantage lies in its form factor and continuous tracking, potentially appealing to users who find cuffs inconvenient or uncomfortable.
According to the Forbes hands-on report, the band is comfortable for all-day wear and the app provides clear, actionable insights. Early tests suggest accuracy that rivals traditional monitors, though independent validation is pending. The launch timing—mid-2026—positions Hilo Core as an early mover in optical blood pressure wearables, though the field is evolving quickly.
Industry analysts note that optical blood pressure monitoring has been technically challenging due to motion artifacts and calibration needs. If Hilo Core delivers on accuracy, it could accelerate adoption of wearables in chronic disease management. The company has not disclosed pricing or whether the device is FDA-cleared, a critical factor for medical credibility.
Looking ahead, Hilo Core must navigate regulatory hurdles and compete with upcoming entries from larger tech firms. A smartphone app update and additional sensor features are expected later this year. For now, early adopters have a new tool to track cardiovascular health—one that promises to make blood pressure monitoring as routine as checking a watch.
Health
↑ Positive
Hilo Core Blood Pressure Smart Wearable Band Launches In U.S. — Hands-On
Hilo Core is a wrist band that tracks blood pressure with optical sensors and reports to an in-depth smartphone app. It’s now launching in the U.S.
David Phelan, Senior Contributor
Forbes
2 min read
6/10
United States
Key Takeaways
- Hilo Core uses optical PPG sensors to measure blood pressure without a traditional cuff, launching in the U.S. in July 2026.
- The device pairs with a smartphone app that provides trend analysis, reports, and alerts for irregular readings.
- Optical blood pressure wearables are a growing segment, with Hilo Core competing against cuff-based monitors from Omron and Withings.
- The Forbes hands-on review highlights the band's comfort for all-day wear and the app's user-friendly interface.
- Hilo Core's launch positions it as an early entrant in the optical BP wearable market, though FDA clearance status remains undisclosed.
Frequently Asked Questions
Hilo Core is a smart wearable wristband that uses optical sensors to measure blood pressure continuously and syncs data to a smartphone app.
It uses photoplethysmography (PPG) sensors to detect blood volume changes through the skin, then algorithms estimate systolic and diastolic pressure.
Yes, Hilo Core launched in the U.S. in July 2026, as reported by Forbes in a hands-on review.
Hilo Core is a consumer wearable, not a medical device, so it does not require a prescription, but users should consult their doctor for clinical decisions.
The app displays blood pressure trends, daily averages, and alerts for abnormal readings, and can generate reports for sharing with healthcare providers.
Early hands-on reviews suggest accuracy rivaling traditional cuff monitors, but independent clinical validation is still pending.
Topics
Original source
www.forbes.com
Discussion
Join the discussion
Sign in to post a comment or reply.
No comments yet. Be the first to share your thoughts!